Pecci F, Thummalapalli R, Alden SL, Ricciuti B, et al. Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non-Small Cell Lung Cancer. Clin Cancer Res 2025 Apr 18:OF1-OF13. doi: 10.1158/1078-0432.CCR-24-2990.
PMID: 40247431